Portable Oxygen Concentrators

In accordance with Federal Regulations, Denver Air Connection permits the carriage and use of portable oxygen concentrators aboard KLA aircraft provided the following conditions are met:

  • Is legally marketed in the United States in accordance with Food and Drug Administration requirements in title 21 of the CFR;
  • Does not radiate radio frequency emissions that interfere with aircraft systems;
  • Generates a maximum oxygen pressure of less than 200 kPa gauge (29.0 psig/43.8 psia) at 20 °C (68 °F);
  • Does not contain any hazardous materials subject to the Hazardous Materials Regulations (49 CFR parts 171 through 180) except as provided in 49 CFR 175.10 for batteries used to power portable electronic devices and that do not require aircraft operator approval; and
  • Bears a label on the exterior of the device applied in a manner that ensures the label will remain affixed for the life of the device and containing the following certification statement in red lettering: “The manufacturer of this POC has determined this device conforms to all applicable FAA acceptance criteria for POC carriage and use on board aircraft.” The label requirements in this paragraph do not apply to the following portable oxygen concentrators approved by the FAA for use on board aircraft prior to May 24, 2016:
    • AirSep Focus;
    • AirSep FreeStyle;
    • AirSep FreeStyle 5;
    • AirSep LifeStyle;
    • Delphi RS-00400;
    • DeVilbiss Healthcare iGo;
    • Inogen One;
    • Inogen One G2;
    • Inogen One G3;
    • Inova Labs LifeChoice;
    • Inova Labs LifeChoice Activox;
    • International Biophysics LifeChoice;
    • Invacare Solo2;
    • Invacare XPO2;
    • Oxlife Independence Oxygen Concentrator;
    • Oxus RS-00400;
    • Precision Medical EasyPulse;
    • Respironics EverGo;
    • Respironics SimplyGo;
    • SeQual Eclipse;
    • SeQual eQuinox Oxygen System (model 4000);
    • SeQual Oxywell Oxygen System (model 4000);
    • SeQual SAROS; and
    • VBox Trooper Oxygen Concentrator.

If you require the use of a portable oxygen concentrator during flight, please notify our call center at least 24 hours prior to departure.

Passengers using portable oxygen concentrators must not occupy exit row seats.

During movement on the surface, takeoff and landing, the device must be stowed under the seat in front of the user, or in another approved stowage location so that it does not block the aisle way or the entryway to the row. If the device is to be operated by the user, it must be operated only at a seat location that does not restrict any passenger's access to, or use of, any required emergency or regular exit, or the aisle(s) in the passenger compartment.

Due the the limited under-seat space on the Metro 23, some portable oxygen concentrators may not be used aboard the Metro 23. If you are flying aboard our Metro 23, please contact our call center in advance to determine if your portable oxygen concentrator will fit.

The user of the portable oxygen concentrator must comply with the following conditions to use the device on board the aircraft:

  1. The user must be capable of hearing the unit's alarms, seeing the alarm light indicators, and have the cognitive ability to take the appropriate action in response to the various caution and warning alarms and alarm light indicators, or be travelling with someone who is capable of performing those functions;
  2. The user must ensure that the portable oxygen concentrator is free of oil, grease or other petroleum products and is in good condition free from damage or other signs of excessive wear or abuse;
  3. The user must inform the aircraft operator that he or she intends to use a portable oxygen concentrator on board the aircraft and must allow the crew of the aircraft to review the contents of the physician's statement. The user must have a written statement, to be kept in that person's possession, signed by a licensed physician that:
    1. States whether the user of the device has the physical and cognitive ability to see, hear, and understand the device's aural and visual cautions and warnings and is able, without assistance, to take the appropriate action in response to those cautions and warnings;
    2. States whether or not oxygen use is medically necessary for all or a portion of the duration of the trip; and
    3. Specifies the maximum oxygen flow rate corresponding to the pressure in the cabin of the aircraft under normal operating conditions.
  4. Only lotions or salves that are oxygen approved may be used by persons using the portable oxygen concentrator device;
  5. The user, whose physician statement specifies the duration of oxygen use, must obtain from the aircraft operator, or by other means, the duration of the planned flight. The user must carry on the flight a sufficient number of batteries to power the device for the duration of the oxygen use specified in the user's physician statement, including a conservative estimate of any unanticipated delays; and
  6. The user must ensure that all portable oxygen concentrator batteries carried onboard the aircraft in carry-on baggage are protected from short circuit and are packaged in a manner that protects them from physical damage. Batteries protected from short circuit include: (1) Those designed with recessed battery terminals; or (2) those packaged so that the battery terminals do not contact metal objects (including the battery terminals of other batteries). When a battery-powered oxygen concentrator is carried onboard aircraft as carry-on baggage and is not intended to be used during the flight, the battery must be removed and packaged separately unless the concentrator contains at least two effective protective features to prevent accidental operation during transport.